checkpoint inhibitors

Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Roche
Pfizer
Merck
Tecentriq
clinical trials
cancer
checkpoint inhibitors
With Positive Data, Checkpoint Looks to Add Second Indication to BLA
BioSpace
Thu, 06/16/22 - 11:11 pm
Checkpoint Therapeutics
FDA
cosibelimab
checkpoint inhibitors
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
Thu, 06/25/20 - 08:36 pm
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
Stat
Wed, 05/29/19 - 09:41 am
type 1 diabetes
checkpoint inhibitors
cancer
What causes immuno-oncology drug resistance? 2 research teams uncover clues
Fierce Biotech
Fri, 04/5/19 - 10:32 am
R&D
immuno-oncology
checkpoint inhibitors
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
Wed, 07/25/18 - 09:49 am
BeiGene
tislelizumab
checkpoint inhibitors
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
Tue, 05/1/18 - 09:16 pm
NeoImmune Tech
Genexine
Roche
HyLeukin-7
checkpoint inhibitors
melanoma
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
CP Wire
Wed, 04/25/18 - 09:55 am
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Tue, 04/24/18 - 11:17 pm
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune conditions
Science
Fri, 11/17/17 - 11:24 am
cancer
checkpoint inhibitors
autoimmune disease
type 1 diabetes